These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 3510005)

  • 1. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.
    Kajita T; Hugli TE
    Am J Pathol; 1991 Jun; 138(6):1359-69. PubMed ID: 2053593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.
    Schick B; Austen KF
    J Immunol; 1986 May; 136(10):3812-8. PubMed ID: 2939135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of human C3a and the synthetic nonapeptide C3a (tyr-70-77) to rat peritoneal mast cells.
    Gervasoni JE; Ruddy S
    Prog Clin Biol Res; 1989; 297():221-31; discussion 231-2. PubMed ID: 2587586
    [No Abstract]   [Full Text] [Related]  

  • 8. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.
    Schick B
    Immunology; 1990 Mar; 69(3):423-8. PubMed ID: 2312165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.
    Schick B; Austen KF; Schwartz LB
    J Immunol; 1984 May; 132(5):2571-7. PubMed ID: 6425408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.
    DuBuske L; Austen KF; Czop J; Stevens RL
    J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase.
    Sommerhoff CP; Ruoss SJ; Caughey GH
    J Immunol; 1992 May; 148(9):2859-66. PubMed ID: 1573274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid microwave fixation of rat mast cells. I. Localization of granule chymase with an ultrastructural postembedding immunogold technique.
    Login GR; Galli SJ; Morgan E; Arizono N; Schwartz LB; Dvorak AM
    Lab Invest; 1987 Nov; 57(5):592-9. PubMed ID: 3479651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase.
    Craig SS; Schwartz LB
    Lab Invest; 1990 Oct; 63(4):581-5. PubMed ID: 2232709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an antiserum specific for cell surface antigens of rat mast cells.
    Yiu SH; Froese A
    J Immunol; 1976 Jul; 117(1):269-73. PubMed ID: 58933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell chymase. A potent secretagogue for airway gland serous cells.
    Sommerhoff CP; Caughey GH; Finkbeiner WE; Lazarus SC; Basbaum CB; Nadel JA
    J Immunol; 1989 Apr; 142(7):2450-6. PubMed ID: 2494259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
    Atkins FM; Metcalfe DD
    J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.